A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation

Oncogene

Volumn 27, Issue 39, 2008, Pages 5195-5203

  Lin, S H ^a   Cheng, C J ^b   Lee, Y C ^a   Ye, X ^a   Tsai, W W ^a   Kim, J ^a   Pasqualini, R ^a   Arap, W ^a   Navone, N M ^a   Tu, S M ^a   Hu, M ^a   Yu Lee, L Y ^c   Logothetis, C J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bone metastasis; Osteoblast; p45 sErbB3; Prostate cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 3; GLYCOSYLATED PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BONE METASTASIS; CANCER CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCID MOUSE;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BONE DEVELOPMENT; BONE NEOPLASMS; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; HUMANS; MALE; MICE; OSTEOBLASTS; PROSTATIC NEOPLASMS; RECEPTOR, ERBB-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MUS;

EID: 51349102459     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.156     Document Type: Article

References (19)

1. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA et al. (1995). Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10: 1813-1821.
2. Berruti A, Dogliotti L, Bitossi R, Fasolis G, Gorzegno G, Bellina M et al. (2000). Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline. J Urol 164: 1248-1253.
3. Bhargava U, Bar-Lev M, Bellows CG, Aubin JE. (1988). Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone 9: 155-163.
4. Chen N, Ye XC, Chu K, Navone NM, Sage EH, Yu-Lee LY et al. (2007). A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. Cancer Res 67: 6544-6548.
5. Choueiri M, Tu S-M, Yu-Lee LY, Lin SH. (2006). The central role of osteoblasts in the metastasis of prostate cancer. Cancer Metastasis Rev 25: 601-609.
6. Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM et al. (2002). Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells. Prostate 52: 20-33.
7. Hellyer NJ, Kim MS, Koland JG. (2001). Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor. J Biol Chem 276: 42153-42161.
8. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. (1989). Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for over-expression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86: 9193-9197.
9. Liang AK, Liu J, Mao SA, Siu VS, Lee YC, Lin SH. (2005). Expression of recombinant MDA-BF-1 with a kinase recognition site and a 7-histidine tag for receptor binding and purification. Protein Expr Purif 44: 58-64.
10. Lin S-H, Lee Y-C, Choueiri M, Wen S, Mathew P, Ye X et al. (2008). Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer. Clin Cancer Res (in press).
11. Logothetis C, Lin S-H. (2005). Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5: 21-28.
12. Low SH, Wong SH, Tang BL, Subramaniam VN, Hong W. (1991). Apical cell surface expression of rat dipeptidyl peptidase IV in transfected madin-darby canine kidney cells. J Biol Chem 266: 13391-13396.
13. Naidu R, Yadav M, Nair S, Kutty MK. (1998). Expression of c-erbB3 protein in primary breast carcinomas. Br J Cancer 78: 1385-1390.
14. Shah RB, Mehra R, Chinnaiyan AM, Shen R, Ghosh D, Zhou M et al. (2004). Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res 64: 9209-9216.
15. Soos G, Zukowski K, Jones RF, Haas GP, Wang CY. (1996). Heterotopic growth of human prostate carcinoma in the femurs of nude mice: an osseous metastatic model. Int J Cancer 66: 280-281.
16. Vakar-Lopez F, Cheng C-J, Kim J, Shi GG, Troncoso P, Tu S-M et al. (2004). Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow. J Pathol 203: 688-695.
17. Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF et al. (1998). Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 77: 887-894.
18. Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N et al. (2001). Prostate cancer cells induce osteoblast differentiation through a cbfa1-dependent pathway. Cancer Res 61: 5652-5659.
19. Yi ES, Harclerode D, Gondo M, Stephenson M, Brown RW, Younes M et al. (1997). High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas. Mod Pathol 10: 142-148.